Skip to main content
. 2021 Apr 3;152:112160. doi: 10.1016/j.fct.2021.112160

Fig. 9.

Fig. 9

The illustration suggests output of descriptive analysis for A. cumulative scaffold recovery (CSR) curves methodology; B. Tanimoto coefficient; and C. Extended-connectivity fingerprints (ECFP4) approach. The research was performed for reported USFDA approved drugs under the anti-infective category during the year 2015–20 and drugs identified using in silico-based studies for natural products.